Pharvaris PHVS Stock
Pharvaris Price Chart
Pharvaris PHVS Financial and Trading Overview
| Pharvaris stock price | 21.9 USD |
| Previous Close | 11.4 USD |
| Open | 11.3 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1200 |
| Day's Range | 11.05 - 11.39 USD |
| 52 Week Range | 1.77 - 27.5 USD |
| Volume | 26.98K USD |
| Avg. Volume | 10.26K USD |
| Market Cap | 377.89M USD |
| Beta (5Y Monthly) | -4.583832 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.83 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.71 USD |
PHVS Valuation Measures
| Enterprise Value | 244.11M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.380392 |
| PEG Ratio (5 yr expected) | -0.16 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.926382 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.762 |
Trading Information
Pharvaris Stock Price History
| Beta (5Y Monthly) | -4.583832 |
| 52-Week Change | -59.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.5 USD |
| 52 Week Low | 1.77 USD |
| 50-Day Moving Average | 8.93 USD |
| 200-Day Moving Average | 7.7 USD |
PHVS Share Statistics
| Avg. Volume (3 month) | 10.26K USD |
| Avg. Daily Volume (10-Days) | 16.59K USD |
| Shares Outstanding | 33.83M |
| Float | 12.58M |
| Short Ratio | 11.35 |
| % Held by Insiders | 9.62% |
| % Held by Institutions | 73.73% |
| Shares Short | 64.87K |
| Short % of Float | 0.23% |
| Short % of Shares Outstanding | 0.19% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.67% |
| Return on Equity (ttm) | -51.82% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -88391784 USD |
| Net Income Avi to Common (ttm) | -82936480 USD |
| Diluted EPS (ttm) | -2.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 135.18M USD |
| Total Cash Per Share (mrq) | 4 USD |
| Total Debt (mrq) | 386.52K USD |
| Total Debt/Equity (mrq) | 0.3 USD |
| Current Ratio (mrq) | 7.955 |
| Book Value Per Share (mrq) | 3.817 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -74486224 USD |
| Levered Free Cash Flow (ttm) | -40899176 USD |
Profile of Pharvaris
| Country | United States |
| State | N/A |
| City | Leiden |
| Address | Emmy Noetherweg 2 |
| ZIP | 2333 CH |
| Phone | 31 71 203 6410 |
| Website | https://pharvaris.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 66 |
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.
Q&A For Pharvaris Stock
What is a current PHVS stock price?
Pharvaris PHVS stock price today per share is 21.9 USD.
How to purchase Pharvaris stock?
You can buy PHVS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharvaris?
The stock symbol or ticker of Pharvaris is PHVS.
Which industry does the Pharvaris company belong to?
The Pharvaris industry is Biotechnology.
How many shares does Pharvaris have in circulation?
The max supply of Pharvaris shares is 53.82M.
What is Pharvaris Price to Earnings Ratio (PE Ratio)?
Pharvaris PE Ratio is now.
What was Pharvaris earnings per share over the trailing 12 months (TTM)?
Pharvaris EPS is -2.83 USD over the trailing 12 months.
Which sector does the Pharvaris company belong to?
The Pharvaris sector is Healthcare.
Pharvaris PHVS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}